GIP-Is are no longer a niche health story. They are reshaping how people eat, choose, and live.
We surveyed nearly 3,000 people across five major economies - and the headline isn't weight loss, it's control.
GLP-Is don't just reduce how much people eat. They reduce how much people want, and can change how people experience taste, texture, and flavor. That is a fundamentally different consumer to design for.
Inside this report you will find:
20 pressure-tested product concepts, ranked from strongest to weakest
Market-specific growth spaces, from compact nourishment to post-treatment support
The full GLP-1 journey - from considerers to current users to life after stopping
And much more!
"One of the most overlooked aspects of the GLP-1 experience is sensory change. These medications do not simply reduce appetite; they can also alter how food tastes, feels, satisfies and is tolerated."
Andrew Wardlaw, Chief Ideas Officer | MMR